PharmacoEconomics & Outcomes News 460 - 28 Aug 2004 ■ By 2009, the global market for inflammatory bowel disorders (IBD) drugs is expected to reach approximately $US2.2 billion, up from about $US1.88 billion in 2004, representing a compound annual growth rate of 8.9%. 1 Meanwhile, the worldwide market for neuropathic pain therapies is expected to reach $US1.1 billion in 2004, increasing to an estimated $US3.5 billion by 2009, representing a compound annual growth rate of 28%. 2 Currently, eleven new products are expected to be launched in the global neuropathic pain market by 2009, including many with blockbuster potential. 1. Research and Markets. Research and Markets: Inflammatory Bowel Disorder Therapeutics: Market Estimated to Grow at a Compound Annual Growth rate of 8.9% with Market Value Reaching Approximately $2.88B Worldwide in 2009. Media Release : 20 Aug 2004. Available from: URL: http://www.researchandmarkets.com. 2. Research and Markets. Research and Markets: Emerging Neuropathic Pain Therapeutics: 11 New Products Expected to be Launched on the Worldwide Market by 2009. Media Release : 20 Aug 2004. Available from: URL: http:/ /www.researchandmarkets.com. 800969472 1 PharmacoEconomics & Outcomes News 28 Aug 2004 No. 460 1173-5503/10/0460-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Market growth tipped for IBD, neuropathic pain therapies by 2009

Download PDF Report

Upload
vodung
View
212
Download
0

Embed Size (px)

Citation preview

Page 1: Market growth tipped for IBD, neuropathic pain therapies by 2009

PharmacoEconomics & Outcomes News 460 - 28 Aug 2004

■ By 2009, the global market for inflammatorybowel disorders (IBD) drugs is expected to reachapproximately $US2.2 billion, up from about$US1.88 billion in 2004, representing a compoundannual growth rate of 8.9%.1 Meanwhile, theworldwide market for neuropathic pain therapies isexpected to reach $US1.1 billion in 2004, increasing toan estimated $US3.5 billion by 2009, representing acompound annual growth rate of 28%.2 Currently,eleven new products are expected to be launched inthe global neuropathic pain market by 2009, includingmany with blockbuster potential.1. Research and Markets. Research and Markets: Inflammatory Bowel

Disorder Therapeutics: Market Estimated to Grow at a Compound AnnualGrowth rate of 8.9% with Market Value Reaching Approximately $2.88BWorldwide in 2009. Media Release : 20 Aug 2004. Available from: URL:http://www.researchandmarkets.com.

2. Research and Markets. Research and Markets: Emerging Neuropathic PainTherapeutics: 11 New Products Expected to be Launched on the WorldwideMarket by 2009. Media Release : 20 Aug 2004. Available from: URL: http://www.researchandmarkets.com.

800969472